# | Drug | Count |
---|---|---|
0 | ADALIMUMAB | 341 |
1 | ETANERCEPT | 321 |
2 | AZATHIOPRINE | 313 |
3 | LEFLUNOMIDE | 310 |
4 | METHOTREXATE SODIUM | 307 |
5 | TOCILIZUMAB | 301 |
6 | CERTOLIZUMAB PEGOL | 299 |
7 | SULFASALAZINE | 296 |
8 | INFLIXIMAB | 280 |
9 | METHOTREXATE | 265 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | SULFACETAMIDE SODIUM AND SULFUR | 1 | 0.0333 |
1 | GOLD | 110 | 0.0277 |
2 | DIMETHYL SULFOXIDE | 4 | 0.0234 |
3 | PIROXICAM | 84 | 0.0138 |
4 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0122 |
5 | SULFASALAZINE | 296 | 0.0050 |
6 | AZATHIOPRINE | 313 | 0.0049 |
7 | CERTOLIZUMAB PEGOL | 299 | 0.0040 |
8 | TOCILIZUMAB | 301 | 0.0038 |
9 | LEFLUNOMIDE | 310 | 0.0037 |
# | Drug class | Count |
---|---|---|
0 | Tumor Necrosis Factor Blocker [EPC] | 329 |
1 | Purine Antimetabolite [EPC] | 313 |
2 | Antirheumatic Agent [EPC] | 310 |
3 | Interleukin-6 Receptor Antagonist [EPC] | 301 |
4 | Aminosalicylate [EPC] | 297 |
5 | Folate Analog Metabolic Inhibitor [EPC] | 264 |
6 | Corticosteroid [EPC] | 117 |
7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 116 |
8 | Selective T Cell Costimulation Modulator [EPC] | 111 |
9 | Standardized Chemical Allergen [EPC] | 110 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Standardized Chemical Allergen [EPC] | 110 | 0.0090 |
1 | Purine Antimetabolite [EPC] | 313 | 0.0046 |
2 | Antirheumatic Agent [EPC] | 310 | 0.0037 |
3 | Interleukin-6 Receptor Antagonist [EPC] | 301 | 0.0034 |
4 | Aminosalicylate [EPC] | 297 | 0.0031 |
5 | Iron Chelator [EPC] | 29 | 0.0011 |
6 | Selective T Cell Costimulation Modulator [EPC] | 111 | 0.0011 |
7 | Folate Analog Metabolic Inhibitor [EPC] | 264 | 0.0008 |
8 | Photoenhancer [EPC] | 1 | 0.0007 |
9 | Farnesoid X Receptor Agonist [EPC] | 3 | 0.0005 |